PUBLIC COMPANY
saveTakeda Pharmaceuticals USA Inc
updated 1mo ago
community read0 votes
pipeline
20
marketed
20
phase 3
0
catalysts ytd
5
approvals ytd
5
recalls ytd
0
Pipeline(20)
view full pipeline →pipeline depth20 products
20Marketed
Marketed
(alogliptin benzoate + metformin hydrochloride)
Type 2 Diabetes
Marketed(alogliptin benzoate + pioglitazone hydrochloride)
Type 2 Diabetes
Marketed(amphetamine aspartate + amfetamine + dextroamphetamine saccharate + dextroamphetamine sulfate) ER
Attention Deficit Hyperactivity Disorder (ADHD)
Marketed(glimepiride + pioglitazone hydrochloride)
Type 2 Diabetes
Marketed(metformin hydrochloride + pioglitazone hydrochloride)
Type 2 Diabetes
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that